Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
出版年份 2015 全文链接
标题
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
作者
关键词
Recurrence Score, FFPE Tissue, Intrinsic Subtype, Proliferation Score, NanoString nCounter
出版物
BMC Medical Genomics
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-08-22
DOI
10.1186/s12920-015-0129-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer--a problem still to be solved
- (2014) M. Schmidt et al. ANNALS OF ONCOLOGY
- Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue
- (2014) D. W. Scott et al. BLOOD
- Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens
- (2014) Torsten Nielsen et al. BMC CANCER
- The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer
- (2014) Martin Filipits et al. CLINICAL CANCER RESEARCH
- Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study
- (2014) A. Prat et al. CLINICAL CANCER RESEARCH
- A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration
- (2014) Lindsay Y King et al. GUT
- Absolute Assignment of Breast Cancer Intrinsic Molecular Subtype
- (2014) Eric R. Paquet et al. JNCI-Journal of the National Cancer Institute
- Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery
- (2014) Jeeyun Lee et al. PLoS One
- PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients
- (2013) Charlotte L. T. Jørgensen et al. ACTA ONCOLOGICA
- Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
- (2013) M. Gnant et al. ANNALS OF ONCOLOGY
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer
- (2013) Miguel Martín et al. BREAST CANCER RESEARCH AND TREATMENT
- A 13-Gene Signature Prognostic of HPV-Negative OSCC: Discovery and External Validation
- (2013) P. Lohavanichbutr et al. CLINICAL CANCER RESEARCH
- Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy
- (2013) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Factors Predicting Late Recurrence for Estrogen Receptor–Positive Breast Cancer
- (2013) Ivana Sestak et al. JNCI-Journal of the National Cancer Institute
- An International Ki67 Reproducibility Study
- (2013) Mei-Yin C. Polley et al. JNCI-Journal of the National Cancer Institute
- Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
- (2013) A. Prat et al. ONCOLOGIST
- PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers
- (2012) Roy RL Bastien et al. BMC Medical Genomics
- PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer
- (2012) A. Prat et al. BREAST CANCER RESEARCH AND TREATMENT
- Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial
- (2012) M. C. U. Cheang et al. CLINICAL CANCER RESEARCH
- A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen
- (2012) S. K. Chia et al. CLINICAL CANCER RESEARCH
- mRNA transcript quantification in archival samples using multiplexed, color-coded probes
- (2011) Patricia P Reis et al. BMC BIOTECHNOLOGY
- Systematic Bias in Genomic Classification Due to Contaminating Non-neoplastic Tissue in Breast Tumor Samples
- (2011) Fathi Elloumi et al. BMC Medical Genomics
- A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response
- (2011) Oscar Krijgsman et al. BREAST CANCER RESEARCH AND TREATMENT
- A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
- (2011) Martin Filipits et al. CLINICAL CANCER RESEARCH
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Gene Expression Profiles of Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancers Are Detectable in Histologically Normal Breast Epithelium
- (2010) K. Graham et al. CLINICAL CANCER RESEARCH
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. Journal of Oncology Practice
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer
- (2009) C. R. Graveel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trial Assessing Individualized Options for Treatment for breast cancer: the TAILORx trial
- (2008) Jo Anne Zujewski et al. Future Oncology
- Clinical Application of the 70-Gene Profile: The MINDACT Trial
- (2008) Fatima Cardoso et al. JOURNAL OF CLINICAL ONCOLOGY
- Direct multiplexed measurement of gene expression with color-coded probe pairs
- (2008) Gary K Geiss et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now